| Schreiber Medical Office | |
|
3010 W Orange Ave Suite 503 Anaheim CA 92804-3169 | |
| (714) 821-8250 | |
| Not Available |
| Full Name | Schreiber Medical Office |
|---|---|
| Speciality | Clinic/center - Primary Care |
| Location | 3010 W Orange Ave, Anaheim, California |
| Authorized Official Name and Position | William Joseph Kopelman (CEO) |
| Authorized Official Contact | 3234232781 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Schreiber Medical Office 2100 Barclay St Los Angeles CA 90031-1204 Ph: () - | Schreiber Medical Office 3010 W Orange Ave Suite 503 Anaheim CA 92804-3169 Ph: (714) 821-8250 |
| NPI Number | 1306276704 |
|---|---|
| Provider Enumeration Date | 11/21/2013 |
| Last Update Date | 01/20/2014 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306276704 | NPI | - | NPPES |
| 1457318164 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | C53462 (California) | Primary |
News Archive
A team of University of Houston pharmaceutical researchers is reporting a newly recognized process of drug metabolism in the intestines - followed by recycling through the liver - that could have important implications for developing treatments for intestinal diseases and for taking multiple medications at the same time.
Treatment-free remission may be feasible in many patients with chronic myeloid leukaemia, say researchers who set out clinical and logistical requirements for discontinuing tyrosine kinase inhibitor therapy.
CIGNA Corporation today reported shareholders' net income of $329 million, or $1.19 per share, for the third quarter of 2009 compared with shareholders' net income of $171 million, or $0.62 per share, for the same period last year. Shareholders' net income for the third quarter 2009 included income related to the variable annuity products within our Run-off Reinsurance segment of $16 million after-tax, or $0.06 per share, primarily related to favorable performance in the equity markets.
"The results of this study are counter to most expectations," said Dr. Brachman, Director of Radiation Oncology at Barrow and St. Joseph's. "Bevacizumab had been shown in earlier studies to be an effective drug in the treatment of patients with recurrent disease. But, on newly diagnosed patients, it did not, in fact, prolong survival."
› Verified 2 days ago
The Family Medicine Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1211 W. La Palma Avenue, Suite #404, Anaheim, CA 92801 Phone: 714-772-1030 Fax: 714-772-1758 | |
Anaheim Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2571 W La Palma Ave, Anaheim, CA 92801 Phone: 714-827-9797 Fax: 714-827-5377 | |
Shirdi Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1751 W Romneya Dr, Anaheim, CA 92801 Phone: 714-776-3180 Fax: 714-991-1932 | |
Rakesh Kumar Bhola ,m.d. Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1781 W Romneya Dr Ste C, Anaheim, CA 92801 Phone: 714-776-2700 | |
Anaheim Health Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 N Magnolia Ave, Anaheim, CA 92801 Phone: 714-484-1280 Fax: 714-484-1358 | |
Richard Dick M Yip Md A Medical Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 408 S Beach Blvd Ste 211, Anaheim, CA 92804 Phone: 714-527-6000 Fax: 714-527-2371 | |
Benevolence Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 303 N East St, Anaheim, CA 92805 Phone: 714-491-1771 |